Leadership Overview
Miracle-Ear has 7 executives leading key functions including operational scaling, strategic partnership management, and regional market development.
Committed to enhancing auditory health through advanced technology, Miracle-Ear delivers personalized hearing solutions that empower individuals to reconnect with the world through superior, discreet, and comfortable medical devices.
Committed to enhancing auditory health through advanced technology, Miracle-Ear delivers personalized hearing solutions that empower individuals to reconnect with the world through superior, discreet, and comfortable medical devices.
Leadership Roles at Miracle-Ear
Al SHrive - Chief Operating Officer
Al SHrive, the Chief Operating Officer at Miracle-Ear, directs all internal business processes and supply chain logistics to ensure seamless delivery of hearing solutions. Overseeing the operational infrastructure, the Chief Operating Officer optimizes manufacturing workflows to maintain high standards for discreet, comfortable medical products. This leadership role involves coordinating with cross-functional teams to scale service delivery across North American markets. By refining internal efficiencies, Al SHrive directly impacts the ability of the organization to meet diverse hearing loss needs with precision. The Chief Operating Officer also monitors performance metrics to drive continuous improvement in product quality and patient satisfaction. Through rigorous oversight of daily operations, SHrive secures the long-term stability of the manufacturing division while supporting the broader mission of providing accessible, high-quality auditory technology to a growing customer base.
Brian Rafferty - President & Chief Operating Officer & Partner
Brian Rafferty, the President & Chief Operating Officer & Partner at Miracle-Ear, manages strategic partnerships and high-level operational growth initiatives. Overseeing the expansion of the partner network, the President & Chief Operating Officer & Partner ensures alignment between corporate objectives and regional service delivery. This leadership role involves cultivating relationships with stakeholders to broaden the reach of customizable hearing solutions. By integrating business development strategies with operational oversight, Brian Rafferty directly influences the market position of the company within the medical manufacturing sector. The President & Chief Operating Officer & Partner also evaluates new opportunities for technological integration to enhance product offerings. Through consistent focus on collaborative growth, Rafferty drives the expansion of the brand, ensuring that the organization remains a trusted resource for individuals seeking advanced, comfortable hearing technology across diverse geographic regions.
Patrick Kochanowski - President and Founder KHIC, Inc.,
Patrick Kochanowski, the President and Founder KHIC, Inc., at Miracle-Ear, drives the strategic vision for specialized regional operations and service excellence. Overseeing the implementation of localized business models, the President and Founder KHIC, Inc., ensures that hearing solutions meet specific community needs with high precision. This leadership role involves guiding the development of customer-centric service protocols that define the brand experience. By fostering a culture of innovation, Patrick Kochanowski directly impacts the effectiveness of hearing loss interventions provided to patients. The President and Founder KHIC, Inc., also collaborates with executive leadership to align regional performance with the overarching goals of the Amplifon Group. Through dedicated focus on operational integrity and patient outcomes, Kochanowski strengthens the market presence of the company, ensuring that advanced auditory technology remains accessible and effective for all individuals requiring support.
Julie Collins - President
Julie Collins, the President at Miracle-Ear, leads the strategic direction for consumer-facing initiatives and brand growth. Overseeing the development of marketing and patient engagement strategies, the President ensures that the value proposition of customizable hearing solutions reaches target demographics effectively. This leadership role involves analyzing market trends to refine the product portfolio and maintain a competitive edge in the medical device industry. By championing patient-centered care, Julie Collins directly influences the reputation and reach of the organization. The President also coordinates with the Board to ensure financial health and long-term sustainability of the business. Through consistent focus on brand excellence and service quality, Collins drives the expansion of the company, ensuring that every individual receives tailored support for hearing loss, thereby solidifying the position of the firm as a leader in auditory health solutions.
Richard Hardy - President
Richard Hardy, the President at Miracle-Ear, manages the execution of enterprise-wide growth strategies and organizational development. Overseeing the alignment of human capital with business objectives, the President ensures that the workforce remains focused on delivering superior hearing technology. This leadership role involves optimizing internal communication channels and fostering a high-performance culture across all departments. By streamlining administrative processes, Richard Hardy directly impacts the agility and responsiveness of the company to changing market demands. The President also evaluates the impact of new technologies on service delivery models to ensure continued innovation. Through strategic planning and rigorous performance management, Hardy secures the operational success of the organization, ensuring that the commitment to providing discreet, comfortable, and effective hearing solutions remains the central focus of all corporate activities and regional operations.
Chad Barthol - President of YBH, Dba Miracle-Ear, Inc.
Chad Barthol, the President of YBH, Dba Miracle-Ear, Inc. at Miracle-Ear, directs the operational activities and service delivery standards for specific regional territories. Overseeing the implementation of clinical protocols, the President of YBH, Dba Miracle-Ear, Inc. ensures that every patient receives high-quality, customized hearing care. This leadership role involves managing local teams to maintain consistency in service quality and brand adherence. By monitoring regional performance data, Chad Barthol directly impacts the success of the company in capturing market share and improving patient outcomes. The President of YBH, Dba Miracle-Ear, Inc. also collaborates with corporate leadership to integrate new product features into the local service model. Through dedicated focus on operational excellence and patient satisfaction, Barthol strengthens the regional footprint of the organization, ensuring that advanced hearing solutions are delivered with care and professional expertise.
James Narducci - President
James Narducci, the President at Miracle-Ear, oversees the strategic integration of advanced diagnostic tools and patient care methodologies. Directing the research and development liaison efforts, the President ensures that the latest technological advancements in hearing solutions are effectively deployed to the end user. This leadership role involves managing the interface between clinical requirements and product engineering to enhance the comfort and efficacy of hearing devices. By prioritizing innovation, James Narducci directly impacts the ability of the company to address complex hearing loss needs. The President also works with executive peers to align product roadmaps with long-term business goals. Through consistent focus on technological advancement and patient-centric design, Narducci drives the evolution of the brand, ensuring that the organization continues to provide industry-leading, discreet, and highly effective auditory solutions to a diverse and global patient population.
Explore Leadership Teams in Manufacturing
Insulet Corporation, headquartered in Massachusetts, is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas.
Company Leadership
JH
CB

CooperVision is committed to helping people around the world see better every day. Through scientific and technological innovation, operational excellence and close working relationships with our eye care professional customers, CooperVision has helped improve the vision of millions and become a trusted global leader in the contact lens industry. CooperVision designs and manufactures innovative, high quality contact lenses to meet a remarkably wide range of wearer needs. We conduct extensive ongoing research and development in optical science. And we collaborate closely with eye care professionals, who help us identify the evolving needs of contact lens wearers around the world.
Company Leadership CH
MW

MA
Accuray develops and manufactures advanced radiation oncology systems designed to deliver precise cancer treatment solutions. The company specializes in creating innovative medical devices that enable clinicians to target tumors with exceptional accuracy while minimizing exposure to surrounding healthy tissue. This focus on precision has shaped the organization's technical approach and product development strategy across its portfolio. The company's radiation oncology systems integrate sophisticated imaging, planning, and delivery technologies to support comprehensive cancer care. By combining real-time imaging capabilities with adaptive treatment planning, Accuray's platforms allow medical teams to adjust therapy in response to anatomical changes during treatment courses. This technological integration addresses a critical challenge in oncology: maintaining treatment efficacy while reducing potential side effects that can impact patient quality of life. Accuray serves hospitals, cancer treatment centers, and specialized radiation oncology facilities globally. The company's systems support treatment of various cancer types across different anatomical sites, from brain and head-and-neck tumors to thoracic and abdominal malignancies. Healthcare providers rely on Accuray's technology to expand their treatment capabilities and improve clinical outcomes for patients who might otherwise have limited options.
Company Leadership

KT
Ansell is a global manufacturer specializing in health and safety protection solutions. Founded in 1893, the company designs and produces a comprehensive range of protective equipment and products that enhance human wellbeing across various industries. Ansell operates internationally with a presence in North America, Europe, Asia Pacific, and other regions, offering innovative safety solutions for industrial, medical, and consumer applications.
Company Leadership NS


CD